Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production

Show other versions (1)

Bibliographic Details
Main Authors:	Ogg, G, Salimi, S, Xue, L, Jolin, H, Hardman, C, Cousins, D, McKenzie, A
Format:	Journal article
Published:	American Association of Immunologists 2015

Similar Items

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
by: Salimi, M, et al.
Published: (2015)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
by: Xue, L, et al.
Published: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
by: Xue, L, et al.
Published: (2014)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
by: Hardman, C, et al.
Published: (2017)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
by: Xue, L, et al.
Published: (2018)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
by: Hardman, CS, et al.
Published: (2021)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
by: Salimi, M, et al.
Published: (2014)

Recognition of viral hemagglutinins by NKp44 but not by NKp30.
by: Arnon, T, et al.
Published: (2001)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
by: Sandham, D, et al.
Published: (2019)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
by: Chen, W, et al.
Published: (2018)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
by: Hardman, C, et al.
Published: (2019)

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
by: Salimi, M, et al.
Published: (2013)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
by: Luo, J, et al.
Published: (2019)

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.
by: Arnon, T, et al.
Published: (2005)

MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.
by: Oliphant, C, et al.
Published: (2016)

Lymphoid microenvironments and innate lymphoid cells in the gut.
by: Pearson, C, et al.
Published: (2012)

Lymphoid microenvironments and innate lymphoid cells in the gut
by: Pearson, C, et al.
Published: (2012)

Innate lymphoid cells--a proposal for uniform nomenclature.
by: Spits, H, et al.
Published: (2013)

Activated innate lymphoid cell populations accumulate in human tumour tissues
by: Salimi, M, et al.
Published: (2018)

Identification and functional analysis of type 2 innate lymphoid cells in the skin and in lesional skin biopsies of patients with atopic dermatitis
by: Salimi, M
Published: (2014)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
by: Hinks, T, et al.
Published: (2017)

Investigating functions of human group 2 innate lymphoid cells in health and disease
by: Nahler, J
Published: (2021)

Innate lymphoid cells in intestinal inflammation
by: Geremia, A, et al.
Published: (2017)

Innate lymphoid cells in models of IBD
by: Pearson, C, et al.
Published: (2012)

Effects of steroids in cultured human type-2 cytokine producing cells
by: Luo, J, et al.
Published: (2018)

Innate Lymphoid Cells in the central nervous system
by: Wang, S, et al.
Published: (2022)

The role of innate lymphoid cells in intestinal inflammation
by: Schaupp, A
Published: (2015)

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
by: Nielsen, N, et al.
Published: (2014)

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
by: Buonocore, S, et al.
Published: (2010)

The role of innate lymphoid cells in colitis-associated cancer
by: Kirchberger, S, et al.
Published: (2012)

Brief report: group 3 innate lymphoid cells in human enthesis
by: Cuthbert, R, et al.
Published: (2017)

Expression of FOXP2 is up-regulated in lymphoid malignancies
by: Campbell, A, et al.
Published: (2009)

Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species
by: Shen, Zeli, et al.
Published: (2020)

Expressions of toll-like receptors and cytokine modulation of antiviral innate immune responses in feline infectious peritonitis virus infection
by: Megat Mazhar Khair, Megat Hamzah
Published: (2020)

The mannose receptor is expressed by subsets of APC in non-lymphoid organs
Published: (2005)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
by: Salimi, M, et al.
Published: (2017)

Enhanced isolation of lymphoid cells from human skin.
by: Salimi, M, et al.
Published: (2016)

Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis
by: Ardain, Amanda, et al.
Published: (2020)

The pattern of Ki-67 and bcl-2 expression in Lymphoid Malignancies
by: Wang, P.L., et al.
Published: (1997)

Chemokine receptor expression and cytokine production of HBV-specific CD8 cells
by: Larrubia, JR, et al.
Published: (2000)